Endometrioid Adenocarcinoma

Endometrioid adenocarcinoma is staged according to the FIGO staging system, which includes four stages:

1. Stage I

tumor confined to the endometrium.

2. Stage II

tumor invades the myometrium but does not extend beyond the uterus.

3. Stage III

tumor spreads outside the uterus but does not involve pelvic lymph nodes or distant metastases.

4. Stage IV

tumor involves pelvic lymph nodes or distant metastases.

Staging is usually determined based on postoperative pathology, including evaluation of tumor size, depth of invasion, lymph node metastasis, etc. Treatment options and prognosis may vary according to stage. Patients in early stages (stages I and II) are usually treated surgically, which may include total hysterectomy and bilateral adnexectomy, and possibly lymph node dissection. For patients in advanced stages (stages III and IV), treatment may include comprehensive treatment methods such as surgery, radiotherapy, and chemotherapy.

It should be noted that staging is only a method of evaluating tumors, and each patient's condition is unique. Treatment plans should be formulated based on individual circumstances. In addition, regular follow-up and monitoring are essential for early detection of recurrence and metastasis. The doctor will make the most appropriate treatment plan according to the specific situation of the patient, taking into account factors such as stage, age and health status. If there is any doubt about the stage or treatment of endometrial adenocarcinoma, it is recommended to consult a professional gynecologic oncologist or medical team.